Cargando…
Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations
The concomitant occurrence of hypertrophic cardiomyopathy and congenital heart defect in patients with RASopathies has previously been reported as associated to a worse clinical outcome, particularly closed to cardiac surgery. Different mechanisms of disease have been demonstrated to be associated w...
Autores principales: | Calcagni, Giulio, Digilio, Maria Cristina, Marino, Bruno, Tartaglia, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610955/ https://www.ncbi.nlm.nih.gov/pubmed/31277675 http://dx.doi.org/10.1186/s13023-019-1151-0 |
Ejemplares similares
-
LEOPARD syndrome in an infant with severe hypertrophic cardiomyopathy and PTPN11 mutation
por: Ganigara, Madhusudan, et al.
Publicado: (2011) -
Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort
por: Chen, Hao, et al.
Publicado: (2019) -
Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy
por: Caiazza, Martina, et al.
Publicado: (2020) -
Rare copy number variations containing genes involved in RASopathies: deletion of SHOC2 and duplication of PTPN11
por: Chen, Jin-Lan, et al.
Publicado: (2014) -
Data on cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results
por: Calcagni, Giulio, et al.
Publicado: (2017)